ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

NSABP Researcher Committed Misconduct, NIH Investigation Finds

March 18, 1994

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994